Major histocompatibility complex class II (HLA-DRB and -DQB) allele frequencies in Botswana: association with human immunodeficiency virus type 1 infection
- PMID: 16148166
- PMCID: PMC1235800
- DOI: 10.1128/CDLI.12.9.1020-1028.2005
Major histocompatibility complex class II (HLA-DRB and -DQB) allele frequencies in Botswana: association with human immunodeficiency virus type 1 infection
Abstract
Southern Africa is facing an unprecedented public health crisis due to the high prevalence of human immunodeficiency virus type 1 (HIV-1). Vaccine development and testing efforts, mainly based on elicitation of HIV-specific T cells, are under way. To understand the role of human leukocyte antigen (HLA) class II alleles in HIV pathogenesis and to facilitate HLA-based HIV-1 vaccine design, we analyzed the frequencies of HLA class II alleles within the southern African country of Botswana. Common HLA class II alleles were identified within the Botswana population through the molecular genotyping of DRB and DQB1 loci. The DRB1 allele groups DRB1*01, DRB1*02/15, DRB1*03, DRB1*11, and DRB1*13 were encountered at frequencies above 20%. Within the DQB1 locus, DQB1*06 (47.7%) was the most common allele group, followed by DQB1*03 (39.2%) and DQB1*04 (25.8%). We found that DRB1*01 was more common in HIV-negative than in HIV-positive individuals and that those who expressed DRB1*08 had lower median viral loads. We demonstrate that the frequencies of certain HLA class II alleles in this Botswana population differ substantially from those in North American populations, including African-Americans. Common allele groups within Botswana cover large percentages of other African populations and could be targeted in regional vaccine designs.
Figures


Similar articles
-
Association of HLA-DQ and -DR alleles with protection from or infection with HIV-1.Exp Mol Pathol. 2000 Feb;68(1):21-8. doi: 10.1006/exmp.1999.2287. Exp Mol Pathol. 2000. PMID: 10640451
-
HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.Tissue Antigens. 2007 Dec;70(6):455-63. doi: 10.1111/j.1399-0039.2007.00932.x. Epub 2007 Sep 27. Tissue Antigens. 2007. PMID: 17900288
-
HLA class II diversity in HIV-1 uninfected individuals from the placebo arm of the RV144 Thai vaccine efficacy trial.Tissue Antigens. 2015 Feb;85(2):117-26. doi: 10.1111/tan.12507. Tissue Antigens. 2015. PMID: 25626602 Free PMC article.
-
Influence of host genetics on the severity of coccidioidomycosis.Emerg Infect Dis. 1999 Sep-Oct;5(5):672-80. doi: 10.3201/eid0505.990508. Emerg Infect Dis. 1999. PMID: 10511523 Free PMC article. Review.
-
Correlation Between the Prevalence of Myasthenia Gravis and the Frequency of Class II Human Leucocyte Antigen Alleles in Various Geographical Locations Around the World.Cureus. 2024 Sep 20;16(9):e69791. doi: 10.7759/cureus.69791. eCollection 2024 Sep. Cureus. 2024. PMID: 39308848 Free PMC article. Review.
Cited by
-
High Resolution HLA ∼A, ∼B, ∼C, ∼DRB1, ∼DQA1, and ∼DQB1 Diversity in South African Populations.Front Genet. 2022 Mar 4;13:711944. doi: 10.3389/fgene.2022.711944. eCollection 2022. Front Genet. 2022. PMID: 35309124 Free PMC article.
-
The KT Jeang retrovirology prize 2023: Thumbi Ndung'u.Retrovirology. 2023 Oct 18;20(1):17. doi: 10.1186/s12977-023-00632-9. Retrovirology. 2023. PMID: 37848918 Free PMC article. No abstract available.
-
Major histocompatibility complex class II molecule-human immunodeficiency virus peptide analysis using a microarray chip.Clin Vaccine Immunol. 2009 Apr;16(4):567-73. doi: 10.1128/CVI.00441-08. Epub 2009 Feb 18. Clin Vaccine Immunol. 2009. PMID: 19225081 Free PMC article.
-
Human Leukocyte Antigen Diversity: A Southern African Perspective.J Immunol Res. 2015;2015:746151. doi: 10.1155/2015/746151. Epub 2015 Aug 12. J Immunol Res. 2015. PMID: 26347896 Free PMC article. Review.
-
In Silico Prediction of Human Leukocytes Antigen (HLA) Class II Binding Hepatitis B Virus (HBV) Peptides in Botswana.Viruses. 2020 Jul 6;12(7):731. doi: 10.3390/v12070731. Viruses. 2020. PMID: 32640609 Free PMC article.
References
-
- Altfeld, M., and E. Rosenberg. 2000. The role of CD4+ T helper cells in the cytotoxic T lymphocyte response to HIV-1. Curr. Opin. Immunol. 12:375-380. - PubMed
-
- Amara, R., F. Villinger, J. Altman, S. Lydy, S. O'Neil, S. Staprans, D. Montefiori, Y. Xu, J. Herndon, L. Wyatt, M. Candido, N. Kozyr, P. Earl, J. Smith, H. Ma, B. Grimm, M. Hulsey, J. Miller, H. McClure, J. McNicholl, B. Moss, and H. Robinson. 2001. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 292:69-74. - PubMed
-
- American Society for Histocompatibility and Immunogenetics. 1998. Standards for histocompatibility testing. American Society for Histocompatibility and Immunogenetics, Lenexa, Kans.
-
- Barouch, D., J. Kunstman, M. Kuroda, J. Schmitz, S. Santra, F. Peyerl, G. Krivulka, K. Beaudry, M. Lifton, D. Gorgone, D. Montefiori, M. Lewis, S. Wolinsky, and N. Letvin. 2002. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature 415:272-273. - PubMed
-
- Barouch, D., S. Santra, J. Schmitz, M. Kuroda, T. Fu, W. Wagner, M. Bilska, A. Craiu, X. Zheng, G. Krivulka, K. Beaudry, M. Lifton, C. Nickerson, W. Trigona, K. Punt, D. Freed, L. Guan, S. Dubey, D. Casimiro, A. Simon, M. Davies, M. Chastain, T. Strom, R. Gelman, D. Montefiori, M. Lewis, E. Emini, J. Shiver, and N. Letvin. 2000. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science 290:486-492. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials